异氰酸4-(6-甲基-2-苯并噻唑基)苯酯 | 67229-93-0

• 物质功能分类: 分析化学 - 分析试剂 - 常用分析试剂
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 中文名称: 异氰酸4-(6-甲基-2-苯并噻唑基)苯酯
• 中文别名: 4-(6-甲基-2-苯并噻唑基)异氰酸苯酯；4-(6-甲基-2-苯并噻唑)异氰酸苯酯
• 英文名称: 4-(6-methyl-2-benzothiazolyl)phenyl isocyanate
• 英文别名: 2-(4-isocyanatophenyl)-6-methylbenzothiazole；4-(6-methyl-benzothiazol-2-yl)-phenyl isocyanate；4-(6-Methyl-benzothiazol-2-yl)-phenylisocyanat；2-(4-isocyanatophenyl)-6-methyl-1,3-benzothiazole
• CAS: 67229-93-0
• 化学式: C₁₅H₁₀N₂OS
• 分子量: 266.323
• InChiKey: DKMGYFQSCKPSEQ-UHFFFAOYSA-N

物化性质

• 熔点：
  140-150 °C (dec.)

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  70.6
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 安全说明：
  S22,S24/25
• WGK Germany：
  3
• 海关编码：
  2934200090

SDS

Version 1.4
Regulation (EC) No 1907/2006

---

1 - Product and Company Information

---

Product Name 4-(6-METHYL-2-BENZOTHIAZOLYL)PHENYL
ISOCYANATE SUITABLE FOR FLUORESCENCE,
PURUM, FOR FLUORESCENCE, >= 98.0% (HPLC)

---

2 - Hazards Identification

---

3 - Composition/Information on Ingredients

---

Product Name CAS # EC no Annex I
Index Number
4-(6-METHYL-2-BENZOTHIAZOLYL)PHENY 67229-93-0 None None
L ISOCYANATE
Formula C15H10N2OS
Molecular Weight 266,3000 AMU

---

4 - First Aid Measures

---

AFTER INHALATION
If inhaled, remove to fresh air. If not breathing give
artificial respiration. If breathing is difficult, give oxygen.
AFTER SKIN CONTACT
In case of contact, immediately wash skin with soap and copious
amounts of water.
AFTER EYE CONTACT
In case of contact, immediately flush eyes with copious amounts
of water for at least 15 minutes.
AFTER INGESTION
If swallowed, wash out mouth with water provided person is
conscious. Call a physician.

---

5 - Fire Fighting Measures

---

EXTINGUISHING MEDIA
SIGMA www.molbase.com
Suitable: Water spray. Carbon dioxide, dry chemical powder, or
appropriate foam.
SPECIAL RISKS
Specific Hazard(s): Emits toxic fumes under fire conditions.
SPECIAL PROTECTIVE EQUIPMENT FOR FIREFIGHTERS
Wear self-contained breathing apparatus and protective clothing
to prevent contact with skin and eyes.

---

6 - Accidental Release Measures

---

PERSONAL PRECAUTION PROCEDURES TO BE FOLLOWED IN CASE OF LEAK OR SPILL
Evacuate area.
PROCEDURE(S) OF PERSONAL PRECAUTION(S)
Wear self-contained breathing apparatus, rubber boots, and heavy
rubber gloves.
METHODS FOR CLEANING UP
Sweep up, place in a bag and hold for waste disposal. Avoid
raising dust. Ventilate area and wash spill site after material
pickup is complete.

---

7 - Handling and Storage

---

HANDLING
Directions for Safe Handling: Do not breathe dust. Do not get in
eyes, on skin, on clothing. Avoid prolonged or repeated exposure.
STORAGE
Conditions of Storage: Keep tightly closed. Store in a cool dry
place.
Store at 2-8°C

---

8 - Exposure Controls / Personal Protection

---

ENGINEERING CONTROLS
Safety shower and eye bath. Use only in a chemical fume hood.
GENERAL HYGIENE MEASURES
Wash thoroughly after handling.
PERSONAL PROTECTIVE EQUIPMENT
Special Protective Measures: Wear appropriate government approved
respirator, chemical-resistant gloves, safety goggles, other
protective clothing.

---

9 - Physical and Chemical Properties

---

Appearance Color: Faintly beige
Form: Fine crystals
Property Value At Temperature or Pressure
pH N/A
BP/BP Range N/A
MP/MP Range 140,000 °C
Flash Point N/A
Flammability N/A
SIGMA www.molbase.com
Autoignition Temp N/A
Oxidizing Properties N/A
Explosive Properties N/A
Explosion Limits N/A
Vapor Pressure N/A
Partition Coefficient N/A
Viscosity N/A
Vapor Density N/A
Saturated Vapor Conc. N/A
Evaporation Rate N/A
Bulk Density N/A
Decomposition Temp. N/A
Solvent Content N/A
Water Content N/A
Surface Tension N/A
Conductivity N/A
Miscellaneous Data N/A
Solubility N/A

---

10 - Stability and Reactivity

---

STABILITY
Stable: Stable.
Conditions to Avoid: Moisture.
Materials to Avoid: Strong oxidizing agents.
HAZARDOUS DECOMPOSITION PRODUCTS
Hazardous Decomposition Products: Carbon monoxide, Carbon dioxide,
Nitrogen oxides, Sulfur oxides, Hydrogen cyanide.
HAZARDOUS POLYMERIZATION
Hazardous Polymerization: Will not occur

---

11 - Toxicological Information

---

SENSITIZATION
Sensitization: Prolonged or repeated exposure may cause allergic
reactions in certain sensitive individuals.
SIGNS AND SYMPTOMS OF EXPOSURE
To the best of our knowledge, the chemical, physical, and
toxicological properties have not been thoroughly investigated.
Symptoms of exposure may include burning sensation, coughing,
wheezing, laryngitis, shortness of breath, headache, nausea, and
vomiting.
ROUTE OF EXPOSURE
Inhalation: Material is irritating to mucous membranes and upper
respiratory tract.
Multiple Routes: Causes eye and skin irritation. Harmful if
swallowed, inhaled, or absorbed through skin.

---

12 - Ecological Information

---

No data available.

---

13 - Disposal Considerations

---

SUBSTANCE DISPOSAL
Dissolve or mix the material with a combustible solvent and burn
SIGMA www.molbase.com
in a chemical incinerator equipped with an afterburner and
scrubber. Observe all federal, state, and local environmental
regulations.

---

14 - Transport Information

---

RID/ADR
Non-hazardous for road transport.
IMDG
Non-hazardous for sea transport.
IATA
Non-hazardous for air transport.

---

15 - Regulatory Information

---

CLASSIFICATION AND LABELING ACCORDING TO EU DIRECTIVES
S-PHRASES: 22-24/25
Do not breathe dust. Avoid contact with skin and eyes.
Caution: Substance not yet fully tested (EU).
COUNTRY SPECIFIC INFORMATION
Germany
WGK: 3
Self-Classification

---

16 - Other Information

---

WARRANTY
The above information is believed to be correct but does not
purport to be all inclusive and shall be used only as a guide. The
information in this document is based on the present state of our
knowledge and is applicable to the product with regard to
appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Inc.,
shall not be held liable for any damage resulting from handling or
from contact with the above product. See reverse side of invoice
or packing slip for additional terms and conditions of sale.
Copyright 2010 Co. License granted to make
unlimitedpaper copies for internal use only.
DISCLAIMER
For R&D use only. Not for drug, household or other uses.
SIGMA www.molbase.com

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  异氰酸4-(6-甲基-2-苯并噻唑基)苯酯 、 5-氨基-5-脱氧胸腺嘧啶脱氧核苷 以 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 生成 N-(5'-deoxy-thymidin-5'-yl)-N'-(4-(6-methyl-2-benzothiazolyl)phenyl)urea
  参考文献：
  名称：

  α-胸苷类似物作为新型抗疟药的合成与评价

  摘要：

  恶性疟原虫胸苷酸激酶 ( Pf TMPK) 是嘧啶核苷酸生物合成的关键酶。3-Trifluoromethyl-4-chloro-phenyl-urea-α-thymidine 已被报道为结核分枝杆菌TMPK ( Mt TMPK)的抑制剂。从这一点出发，我们设计、合成并评估了许多作为抗疟药的胸苷类似物。5'-尿素-α-和β-胸苷衍生物都是Pf TMPK 的中度抑制剂，并且还显示出对寄生虫生长的中度抑制。几种酶-抑制剂复合物的结构为改进抑制剂设计提供了基础。然而，我们发现某些 5'-尿素-α-胸苷类似物具有抗疟活性，其中PfTMPK 不是主要的作用方式。该系列的优化产生了具有有效抗疟活性的化合物（EC 50 = 28 nM；CC 50 = 29 μM）。

  DOI：

  10.1021/jm301328h
• 作为产物：
  描述：

  光气 、 2-(4-氨基苯基)-6-甲基苯并噻唑 在 甲苯 、 苯 作用下， 生成 异氰酸4-(6-甲基-2-苯并噻唑基)苯酯
  参考文献：
  名称：

  Weisswange,W., Diss. 49

  摘要：

  DOI：

文献信息

• [EN] SUBSTITUTED QUINOLINE CCR5 RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DU RECEPTEUR CCR5 A BASE DE QUINOLEINE SUBSTITUES
  申请人：SCHERING AG

  公开号：WO2004002960A1

  公开（公告）日：2004-01-08

  The present invention relates to CCR5 receptor antagonists of formulae (1a) or (1b), enantiomers, diastereomers, salts and solvates thereof wherein R1, R2, R3, R4, R5, and R7 are as defined herein. The invention further includes a method of CCR5-mediated disorders employing such compounds.

  本发明涉及式（1a）或（1b）的CCR5受体拮抗剂，其对映体、二对映体、盐和溶剂合物，其中R1、R2、R3、R4、R5和R7如本文所定义。该发明还包括一种利用这些化合物治疗CCR5介导的疾病的方法。
• Transition-metal-free synthesis of aromatic amines via the reaction of benzynes with isocyanates
  作者：Jeong Hoon Seo、Haye Min Ko

  DOI：10.1016/j.tetlet.2018.01.022

  日期：2018.2

  unexpected reaction between benzynes and isocyanates to generate aromatic amines has been developed under transition-metal-free conditions. The in situ prepared anions formed through cleavage of the NC bond in isocyanates, reacted with aryne precursors to afford various aniline derivatives in moderate to excellent yield and tolerated various substituents on the o-silyl aryl triflate and the isocyanate.

  在不含过渡金属的条件下，苯并炔与异氰酸酯发生意外反应生成芳族胺。在原位制备过N开裂而形成的阴离子C键中的异氰酸酯，具有芳炔前体在中等至良好的产率反应，得到各种苯胺衍生物和耐受上各种取代基ø -甲硅烷基三氟甲磺酸的芳基和异氰酸酯。
• Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof
  申请人：JAEHNE Gerhard

  公开号：US20110046185A1

  公开（公告）日：2011-02-24

  The invention relates to compounds of formula (I) wherein the groups R and R′ A, D, E, G, L, p and R1 to R10 have the stated meanings and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs.

  该发明涉及式(I)的化合物，其中基团R和R′ A、D、E、G、L、p以及R1到R10具有所述含义，以及它们的生理相容盐。所述化合物适用于例如作为抗肥胖药物。
• [EN] DERIVATIVES OF PHENYL (THIO) UREA DEOXYTHYMIDINE AND USE THEREOF AS ANTIMALARIALS<br/>[FR] DÉRIVÉS DE PHÉNYL(THIO)URÉEDÉSOXYTHYMIDINE ET LEUR UTILISATION COMME ANTIPALUDIQUES
  申请人：UNIV DUNDEE

  公开号：WO2013014445A1

  公开（公告）日：2013-01-31

  Deoxythymidine derivatives according to formula (I) are disclosed. wherein: X may be O or S; and R1, R2, R3, R4 and R5 may each be independently selected from H, halo, C1-C6 alkyl, C1-C6 haloalkyl, nitro, phenyl, heteroaryl, substituted heteroaryl wherein the substituents may be C1-C6 alkyl or C1-C6 haloalkyl, benzyl, -CH2OAr, -OR6 and six-membered ring heterocyclic groups containing 1 or more O and/or N heteroatoms wherein any N heteroatom may be C1-C6 alkyl-substituted; and R6 may be selected from C1-C6 alkyl, phenyl, six-membered ring heterocyclic groups containing at least one O heteroatom, benzyl and substituted benzyl wherein the substituents may be halo, C1-C6 alkyl or C1-C6 alkoxy; R7 may be H or C1-C6 alkyl; and the stereochemistry of the bond depicted as 〰 is either α or β. Such derivatives have shown good inhibitory activity against malaria-causing parasites, e.g. Plasmodium falciparum, but have shown low levels of toxicity to human cells.

  根据公式（I），披露了脱氧胸苷衍生物。其中：X可以是O或S；R1、R2、R3、R4和R5可以分别独立地选择自H、卤素、C1-C6烷基、C1-C6卤代烷基、硝基、苯基、杂环芳基、取代的杂环芳基，其中取代基可以是C1-C6烷基或C1-C6卤代烷基、苄基、-CH2OAr、-OR6和含有1个或多个O和/或N杂原子的六元环杂环基团，其中任何N杂原子可以是C1-C6烷基取代的；R6可以选择自C1-C6烷基、苯基、含有至少一个O杂原子的六元环杂环基团、苄基和取代的苄基，其中取代基可以是卤素、C1-C6烷基或C1-C6烷氧基；R7可以是H或C1-C6烷基；而所示键的立体化学为α或β。这些衍生物已显示出对引起疟疾的寄生虫，如疟原虫（Plasmodium falciparum），具有良好的抑制活性，但对人类细胞的毒性水平较低。
• [EN] Substituted urea-octatydroindols as antagonists of melanin concentrating hormone receptor 1 (MCH1R)<br/>[FR] UREE-OCTAHYDROINDOLES SUBSTITUES UTILISES EN TANT QU'ANTAGONISTES DU RECEPTEUR 1 DE L'HORMONE CONCENTRANT LA MELANINE (MCH1R)
  申请人：BIOVITRUM AB

  公开号：WO2005051381A1

  公开（公告）日：2005-06-09

  The invention relates to compounds of the general formula (I) wherein R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, Ar, and X are as defined in the description, or a pharmaceutically acceptable salt, hydrates, geometrical isomers, racemates, tautomers, optical isomers, N-oxides and prodrug forms thereof. The compounds may be used for the treatment or prophylaxis of disorders related to the MCH1R receptor and for modulation of appetite. The invention also relates to such use as well as to pharmaceutical formulations comprising a compound of formula (I).

  该发明涉及通式（I）的化合物，其中R0、R1、R2、R3、R4、R5、R6、R7、R8、R9、Ar和X如描述中所定义，或其药学上可接受的盐、水合物、几何异构体、消旋体、互变异构体、光学异构体、N-氧化物及其前药形式。这些化合物可用于治疗或预防与MCH1R受体相关的疾病，并用于调节食欲。该发明还涉及该用途以及包含通式（I）化合物的药物配方。